Skip to main content
Equibles
SOLV logo

SOLV · Solventum Corp · Metrics

Track SOLV — free

Use SOLV with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SOLV.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$86.09 +1.04 (+1.22%)
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$14.48B
Shares
170.22M
Volume · Oct 20 130.81K Avg daily vol (3M) 1.04M

SOLV metrics

97 of 116 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$85.05
Market cap
$14.48B

Price action

20 metrics
Price change (1W)
-0.3%
Price change (30D)
-4.3%
Price change (3M)
+7.3%
Price change (6M)
+21.4%
Price change (YTD)
+7.3%
Price change (1Y)
+17.9%
Trailing year
Price change (5Y)
—
52-week high
$92.44
52-week low
$62.49
Change from 52-week high
-8.0%
Change from 52-week low
+36.1%
Annualized volatility
29.7%
Annualized volatility (3M)
27.6%
Beta
0.6
RSI (14D)
39.8
Price vs SMA 50
-3.9%
Price vs SMA 200
+8.6%
Avg volume (3M)
1.04M
Relative volume
0.8
Average dollar volume
$90.99M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
170.22M

Valuation

12 metrics
P / E (TTM)
10.4
Trailing earnings · reciprocal yield 9.6%
PEG ratio
2.6
EV / revenue
2.3×
reciprocal yield 43.1%
EV / EBITDA
7.5×
reciprocal yield 13.4%
EV / EBIT
9.3×
reciprocal yield 10.8%
P / sales
1.8×
reciprocal yield 56.9%
P / book
3.0
reciprocal yield 32.9%
FCF yield
-0.8%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
69.9
reciprocal yield 1.4%
Earnings yield
9.8%

Historical valuation

8 metrics
P / E historical average (3Y)
18.6×
reciprocal yield 5.4%
P / E historical average (5Y)
18.6×
reciprocal yield 5.4%
EV / revenue historical average (3Y)
2.2×
reciprocal yield 45.3%
EV / revenue historical average (5Y)
2.2×
reciprocal yield 45.3%
EV / EBIT historical average (3Y)
14.6×
reciprocal yield 6.8%
EV / EBIT historical average (5Y)
14.6×
reciprocal yield 6.8%
EV / EBITDA historical average (3Y)
9.8×
reciprocal yield 10.2%
EV / EBITDA historical average (5Y)
9.8×
reciprocal yield 10.2%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
54.7%
Operating margin
25.0%
Trailing 12 months
Net margin
17.3%
Gross profit (TTM)
$4.54B
Operating profit (TTM)
$2.08B
Net income (TTM)
$1.43B
Trailing 12 months
Diluted EPS (TTM)
$8.19
FCF margin
-1.4%
Effective tax rate
15.4%

Per share

11 metrics
Revenue per diluted share (TTM)
$47.50
Gross profit per diluted share (TTM)
$25.98
Operating profit per diluted share (TTM)
$11.85
EBITDA per diluted share (TTM)
$14.74
Net income per diluted share (TTM)
$8.18
Operating cash flow per diluted share (TTM)
$1.21
Free cash flow per diluted share (TTM)
$-0.66
Capital expenditures per diluted share (TTM)
$1.87
R&D per diluted share (TTM)
$4.14
Stock compensation per diluted share (TTM)
$0.95
Book value per share
$29.10

Growth

11 metrics
Revenue growth YoY
+2.2%
Year over year
Net income growth YoY
+2.2%
Revenue (TTM)
$8.31B
Trailing 12 months
EPS growth YoY
+3.9%
Shares change YoY
-1.1%
Year over year · fewer shares
Revenue CAGR (3Y)
+0.8%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
+4.5%
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
29.9%
Return on assets
10.1%
Debt / equity
1.1
Current ratio
1.0
EBITDA (TTM)
$2.58B
Free cash flow (TTM)
−$118.00M
Quick ratio
0.7
Interest coverage
—
Net debt / EBITDA
1.8
Return on invested capital
18.5%
Trailing 12 months
Net cash
−$4.68B
Latest balance sheet
Cash & equivalents
$403.00M
Total assets
$14.24B
Total debt
$5.08B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$209.00M
Capital expenditures (TTM)
$327.00M
R&D (TTM)
$724.00M
SG&A (TTM)
$3.29B
Stock compensation (TTM)
$167.00M
R&D / revenue
8.7%
Stock compensation / revenue
2.0%

Ownership (13F)

3 metrics
13F filers
891
13F filer change QoQ
+3
Institutional ownership
75.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
19.4%

Short interest

3 metrics
Short interest
2.9%
Latest settlement · 5.4 days to cover
Days to cover
5.4d
Short-squeeze score
52 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1964738 CUSIP 83444M101 13F (30d) 138 filings 118 filers Visit website Investor relations